Explore our export-ready active pharmaceutical ingredients, custom peptide compounds, and industrial chemical solutions engineered to international standards.
An authoritative analysis of chemical composition, surface physics, pharmaceutical applications, regulatory frameworks, and global export strategy for enterprise procurement managers.
Simethicone (CAS No. 8050-81-5) is a specialized, hydrophobic liquid mixture containing poly(dimethylsiloxane) (PDMS) silicon polymers stabilized and activated by finely divided silicon dioxide (silica, SiO₂). As a high-performance antifoaming agent, Simethicone acts primarily through physical surface tension reduction rather than biochemical or physiological pathways. The addition of specially surface-treated silica particles enhances the spreading coefficient of the silicone polymer film across gastrointestinal foam bubbles or aqueous chemical solutions, facilitating rapid coalescence and mechanical disruption of surface foam structures.
In pharmaceutical and bioprocessing environments, gas bubbles are stabilized by viscoelastic liquid films comprised of proteins, surfactants, or viscous mucilage. Simethicone operates by inserting itself into the liquid-gas interface. Due to its extremely low surface tension (approximately 20 to 21 mN/m), the compound creates localized surface tension gradients. This instability forces the film to thin precipitously until the capillary pressure breaches the critical threshold, causing immediate coalescence of small microbubbles into larger free bubbles that can be easily eliminated via eructation, flatulence, or mechanical de-aeration systems.
| Specification Parameter | USP / EP Pharmacopeial Standard | Gentolex Grade Benchmark | Analytical Methodology |
|---|---|---|---|
| Appearance | Translucent, greyish-white viscous liquid | Conforms (Homogeneous, particle-free) | Visual / Organoleptic Inspection |
| Assay (Polydimethylsiloxane) | 90.5% – 99.0% | 95.5% – 98.5% | FTIR Quantitative Spectroscopy |
| Silicon Dioxide Content | 4.0% – 7.0% | 5.0% – 6.5% | Gravimetric / Ignition Analysis |
| Kinematic Viscosity (25°C) | 300 – 1000 mPa·s (cSt) | Customized (300, 500, 1000 cSt available) | Rotational Viscometry (ASTM D445) |
| Heavy Metals / Lead Content | ≤ 5 ppm / ≤ 1 ppm | ≤ 1 ppm (Ultra-Pure Standard) | ICP-MS / Atomic Absorption |
| Defoaming Activity Time | ≤ 15 seconds | ≤ 6 seconds (Rapid Breakdown) | USP <741> Foaming Test Apparatus |
The global market for Simethicone and silicone-based antifoam formulations continues to demonstrate stable compound annual growth rates (CAGR exceeding 5.4%), driven by burgeoning demand across pharmaceutical finished dosage forms (FDF), gastroenterology diagnostics, biotechnology fermentation, and food-grade industrial processing. The expansion of over-the-counter (OTC) antacid and anti-gas combination therapeutics (e.g., Simethicone combined with Hydrotalcite, Magaldrate, or Loperamide) accounts for over 45% of total volume consumption globally.
Concurrently, the modern chemical procurement ecosystem faces growing volatility regarding upstream silicon metal raw materials, strict environmental mandates concerning low cyclic siloxane residues (D4, D5, and D6 octamethylcyclotetrasiloxane limits under EU REACH regulations), and demanding cGMP compliance requirements enforced by global regulatory authorities such as the US FDA, EMA, and NMPA. As a result, multinational pharmaceutical manufacturers are increasingly consolidating their sourcing with integrated, audited B2B suppliers and exporters who offer complete regulatory support, low cyclic impurities, and resilient multi-regional distribution networks.
As a non-systemic, physiologically inert agent, Simethicone exhibits immense application versatility across distinct market verticals:
In oral solid dosages (chewable tablets, softgels) and liquid suspensions, Simethicone serves as the primary active ingredient for treating functional gastrointestinal disorders, meteorism, infant colic, and post-operative gas pain. Its compatibility with synthetic active pharmaceutical ingredients (APIs) and peptide complexes makes it a vital inclusion in comprehensive metabolic and digestive health catalogs.
During upper gastrointestinal endoscopy, colonoscopy, and capsule endoscopy, residual intraluminal foam and mucosal gas bubbles severely impair mucosal visualization. Liquid Simethicone formulations administered orally or via endoscopic flush channels break down foam within seconds, providing clear diagnostic fields and minimizing missed lesion detection rates.
In large-scale bioreactors and mammalian cell culture vessels, severe foaming can lead to filter clogging, vessel over-pressurization, medium loss, and biomass denaturation. Industrial-grade Simethicone emulsions act as highly effective, non-toxic defoamers that operate without disrupting gas transfer coefficients (kLa) or fouling downstream ultrafiltration membranes.
Connecting global markets through uncompromised product quality, specialized chemical synthesis, and robust technical support services.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
With an overall factory construction area of 250,000 square meters under international standards, Gentolex offers flexible, scalable, and cost-effective solutions for clients globally. We provide an extensive range of APIs and intermediates for development studies and commercial applications with cGMP standards from long-term collaborations. Complete regulatory documentation and certificates are fully supported for our international client base.
Ensuring full regulatory compliance across North American, European, Latin American, and African pharmaceutical jurisdictions.
Exporting active pharmaceutical ingredients and excipients demands unwavering compliance with international drug master files (DMF) and monograph standards. Gentolex maintains strict quality oversight to ensure that every lot of Simethicone, custom peptide, and raw chemical material adheres to global regulatory frameworks.
Our Quality Assurance team provides comprehensive dossier support to facilitate seamless drug registration and industrial validation:
Understanding the logistical and regulatory nuances of international trade, Gentolex has built operational hubs in Mexico and South Africa. These regional centers provide immediate technical consultation, localized customs clearing oversight, inventory buffering, and flexible payment terms for enterprise clients across Latin America and the African continent.
Pioneering sustainable silicone chemistry, ultra-pure synthetic peptides, and smart defoaming technology.
Collaborating with leading global logistics partners, regulatory agencies, and pharmaceutical enterprises.
Stay informed with technical whitepapers, peptide API breakdowns, and research publications from Gentolex specialists.
Key technical, regulatory, and commercial insights for pharmaceutical procurement directors and chemical formulation engineers.
Discover our complete range of pharmaceutical peptides, weight loss compounds, and advanced chemical intermediates.
